CMMB Earnings Chemomab Therapeutics Ltd.
Reported EPS, revenue and net income by fiscal period (SEC EDGAR) — quarterly and annual. Full financials → Chart & overview → Updated
Annual results
EPS
Net income
ROE
Quarterly results
EPS
Net income
ROE
Reported EPS history
1–8 of 8
| Q1 2023 | 2023-03-31 | 0.04 | 2023-05-11 | 10-Q |
| FY 2022 | 2022-12-31 | 0.12 | 2023-03-20 | 10-K |
| Q3 2022 | 2022-09-30 | 0.09 | 2022-11-10 | 10-Q |
| Q2 2022 | 2022-06-30 | 0.05 | 2022-08-12 | 10-Q |
| Q1 2023 | 2022-03-31 | 0.02 | 2023-05-11 | 10-Q |
| FY 2022 | 2021-12-31 | 0.06 | 2023-03-20 | 10-K |
| Q3 2022 | 2021-09-30 | 0.04 | 2022-11-10 | 10-Q |
| Q2 2022 | 2021-06-30 | 0.02 | 2022-08-12 | 10-Q |
Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Some issuers (e.g. mortgage REITs, banks) don't report a conventional revenue line, so those charts may be omitted. Informational only — not financial advice.